^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Mesothelin/GPC3/GUCY2C-CAR-T

    i
    Other names: Mesothelin/GPC3/GUCY2C-CAR-T
    Associations

    News

    Trials
    Company:
    FAPON
    Drug class:
    Mesothelin-targeted CAR-T immunotherapy, GUCY2C-targeted CAR-T immunotherapy, GPC-3-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    over1year
    Mesothelin-CAR-T Cells Against Cancers (clinicaltrials.gov)
    P1, N=30, Recruiting, Second Affiliated Hospital of Guangzhou Medical University
    New P1 trial • CAR T-Cell Therapy • IO biomarker
    |
    MSLN (Mesothelin)
    |
    MSLN expression • MSLN positive
    |
    Mesothelin/GPC3/GUCY2C-CAR-T